CalciMedica Stock
CalciMedica, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- A. Rachel Leheny
- Employees
- 15
- Market cap
- $3 M
- IPO
- 14/06/2023
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a…
CalciMedica stock: price history
1D
-3.7%
1W
-18.1%
1M
-47.5%
6M
-65.4%
YTD
-96.8%
1Y
-93.6%
2Y
-95.0%
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~43% weaker price swings than usual
Ask the agents about CalciMedica
Analyst assessment of CalciMedica
PRICE TARGET LOW
US$14.00
CONSENSUS
US$266.00
MEDIAN
US$392.00
PRICE TARGET HIGH
US$392.00
0
STRONG BUY
2
BUY
1
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 05/03/2026
CalciMedica stock metrics
P/E
-0.15
P/B
0.65
EV/EBITDA
0.77
RETURN ON EQUITY
-138.8%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
109.8%
FLOAT SHARES
3,457,599
AVG. DAILY VOLUME (30D)
70,735
Insider transactions (SEC)
WILSON ROBERT N
Middleton Fred A
Leheny A. Rachel
Roberts Eric W
Hebbar Sudarshan
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about CalciMedica stock
What does CalciMedica do?
CalciMedica, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is A. Rachel Leheny, the company employs around 15 people.
The IPO was on 14/06/2023; the stock trades on NASDAQ under the ticker CALC.
What do analysts say about CalciMedica stock?
3 analysts rate the stock, the consensus is Buy (as of 05/03/2026).
The average price target is US$266.00, ranging from US$14.00 to US$392.00, with a median of US$392.00.
This is an external assessment, not a statement by Market Jury.
When does CalciMedica report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly -43% stronger than usual.
Does CalciMedica pay a dividend?
No, CalciMedica currently does not pay a dividend.
Which stocks are comparable to CalciMedica?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get CalciMedica stock analyzed?
Clicking "Analyze stock" lets five strategies assess CalciMedica against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.